Sacco E - Search Results

1

Special Issue: "Latest Advances on Urinary Incontinence".

Bientinesi R, Gavi F, Li Marzi V, Sacco E. Bientinesi R, et al. Among authors: sacco e. J Clin Med. 2023 Nov 14;12(22):7075. doi: 10.3390/jcm12227075. J Clin Med. 2023. PMID: 38002688 Free PMC article.

2

[Overactive bladder syndrome: the social and economic perspective].

Sacco E, Bientinesi R, Marangi F, D'Addessi A, Racioppi M, Gulino G, Pinto F, Totaro A, Bassi P. Sacco E, et al. Urologia. 2011 Oct-Dec;78(4):241-56. doi: 10.5301/RU.2011.8886. Urologia. 2011. PMID: 22237808 Review. Italian.

3

Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.

Sacco E, Bientinesi R, Marangi F, Totaro A, D'Addessi A, Racioppi M, Pinto F, Vittori M, Bassi P. Sacco E, et al. BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19. BJU Int. 2012. PMID: 22712582 Clinical Trial.

4

Mirabegron: a review of recent data and its prospects in the management of overactive bladder.

Sacco E, Bientinesi R. Sacco E, et al. Ther Adv Urol. 2012 Dec;4(6):315-24. doi: 10.1177/1756287212457114. Ther Adv Urol. 2012. PMID: 23205058 Free PMC article.

5

OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.

Sacco E, Tienforti D, Bientinesi R, D'Addessi A, Racioppi M, Pinto F, Totaro A, Vittori M, D'Agostino D, Bassi P. Sacco E, et al. Neurourol Urodyn. 2014 Jan;33(1):142-6. doi: 10.1002/nau.22393. Epub 2013 Jul 19. Neurourol Urodyn. 2014. PMID: 23868794

6

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence.

Sacco E, Bientinesi R, Tienforti D, Racioppi M, Gulino G, D'Agostino D, Vittori M, Bassi P. Sacco E, et al. Expert Opin Drug Discov. 2014 Apr;9(4):433-48. doi: 10.1517/17460441.2014.892923. Epub 2014 Feb 22. Expert Opin Drug Discov. 2014. PMID: 24559030 Review.

7

Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?

Sacco E, Bientinesi R. Sacco E, et al. Int Urogynecol J. 2015 May;26(5):629-40. doi: 10.1007/s00192-014-2557-9. Epub 2014 Nov 7. Int Urogynecol J. 2015. PMID: 25377296 Review.

8

[Urinary tract infections.].

Foschi N, Bientinesi R, Palermo G, Pinto F, Bassi PF, Sacco E. Foschi N, et al. Among authors: sacco e. Urologia. 2014 Jul/Sept;81(Suppl 25):16-25. doi: 10.5301/uro.5000080. Epub 2014 Dec 1. Urologia. 2014. PMID: 25451875 Italian.

9

[Antibiotic prophylaxis in urology].

Recupero SM, Bientinesi R, Foschi N, Racioppi M, Bassi PF, Sacco E. Recupero SM, et al. Among authors: sacco e. Urologia. 2014 Oct-Dec;81(4):209-17. doi: 10.5301/uro.5000098. Epub 2014 Dec 5. Urologia. 2014. PMID: 25532466 Review. Italian.

10

[Surgery for male urinary incontinence: where are we now and what is in the pipeline?].

Bientinesi R, Recupero SM, Palermo G, D'Agostino D, Bassi PF, Sacco E. Bientinesi R, et al. Among authors: sacco e. Urologia. 2015 Jul-Sep;82(3):139-50. doi: 10.5301/uro.5000103. Epub 2014 Dec 18. Urologia. 2015. PMID: 25589025 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page